| Literature DB >> 27038808 |
Kalpana Mujoo1, Clayton R Hunt1, Nobuo Horikoshi1, Tej K Pandita2.
Abstract
MOF (males absent on the first) was initially identified as a dosage compensation factor in Drosophila that acetylates lysine 16 of histone H4 (H4K16ac) and increased gene transcription from the single copy male X-chromosome. In humans, however, the ortholog of Drosophila MOF has been shown to interact with a range of proteins that extend its potential significance well beyond transcription. For example, recent results indicate MOF is an upstream regulator of the ATM (ataxia-telangiectasia mutated) protein, the loss of which is responsible for ataxia telangiectasia (AT). ATM is a key regulatory kinase that interacts with and phosphorylates multiple substrates that influence critical, cell-cycle control and DNA damage repair pathways in addition to other pathways. Thus, directly or indirectly, MOF may be involved in a wide range of cellular functions. This review will focus on the contribution of MOF to cellular DNA repair and new results that are beginning to examine the in vivo physiological role of MOF.Entities:
Keywords: DNA DSB; H4K16ac; HR; MOF; NHEJ; Oncogenesis
Mesh:
Substances:
Year: 2016 PMID: 27038808 PMCID: PMC5045309 DOI: 10.1016/j.mad.2016.03.012
Source DB: PubMed Journal: Mech Ageing Dev ISSN: 0047-6374 Impact factor: 5.432